1) Kannel WB, Hjortland MC, McNamara PM, et al : Menopause and risk of cardiovascular disease : the Framingham study. Ann Int Med 85 : 447─452, 1976
2) Writing Group for the Women's Health Initiative Investigators : Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 : 321─33, 2002
3) Writing Group for the Women's Health Initiative Investigators : Effects of conjugated equine estrogen in postmenopausal women with hysterectomy From the Women's Health Initiative randomized controlled trial. JAMA 291 : 1701─1712, 2004
4) Ross R : The pathogenesis of atherosclerosis : a perspective for the 1990s. Nature 362 : 801─809, 1993
5) Simoncini T, Hafezi─Moghadam A, Brazil DP, et al : Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol─3─OH kinase. Nature 407 : 538─541, 2000
6) Hisamoto K, Ohmichi M, Kurachi H, et al : Estrogen induces the Akt─dependent activation of endothelial nitric oxide synthase in vascular endothelial cells. J Biol Chem 276 : 3459─67, 2001
7) Takahashi K, Ohmichi M, Yoshida M, et al : Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. J Endocrinol 178 : 319─329, 2003
8) Mori─Abe A, Tsutsumi S, Takahashi K, et al : Estrogen and raloxifene induce apoptosis by activating p38 mitogen─activated protein kinase cascade in synthetic vascular smooth muscle cells. J Endocrinol 178 : 417─426, 2003
9) Lehmann ED, Riley WA, Clarkson P, et al : Non─invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350 : SI14─119, 1997
10) Ohmichi, M, Kanda, Y, Hisamoto, K, et al : Rapid changes of flow─mediated dilatation after surgical menopause. Maturitas 44 : 125─131, 2003
11) Tomiyama H, Yamashina A, Arai T et al : Influences of age and gender on results of noninvasive brachial─ankle pulse wave velocity measurement──a survey of 12517 subjects. Atherosclerosis 166 : 303─309, 2003
12) Miura S, Tanaka E, Mori A, et al : Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 45 : 293─298, 2003
13) Takahashi K, Tanaka E, Murakami, M et al : Long─term hormone replacement therapy prevents the age related progression of carotid intima─media thickness in healthy postmenopausal women. Maturitas 49 : 170─177, 2004
14) Hsia J, Langer RD, Manson JE, et al : Conjugated equine estrogens and coronary heart disease : the Women's Health Initiative. Archives of Internal Medicine 166 : 357─365, 2006
15) Manson JE, Allison MA, Rossouw JE, et al : Estrogen therapy and coronary─artery calcification. New Engl J Med 356 : 2591─2602, 2007
16) Oishi A, Ohmichi M, Takahashi K, et al : Medroxyprogesterone acetate attenuates estrogen─induced nitric oxide production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 324 : 193─198, 2004
17) Saitoh M, Ohmichi M, Takahashi K, et al : Medroxyprogesterone acetate induces cell proliferation through up─regulation of cyclin D1 expression via phosphatidylinositol 3─kinase/Akt/nuclear factor─kappaB cascade in human breast cancer cells. Endocrinology 146 : 4917─4925, 2005
18) Schairer C, Lubin J, Troisi R, et al : Estrogen─progestin replacement and risk of breast cancer JAMA 284 : 691─694, 2000
19) DeMichele A, Troxel AB, Berlin JA, et al : Impact of raloxifene or tamoxifen use on endometrial cancer risk : a population─based case─control study. J Clin Oncol 26 : 4151─4159, 2008
20) Riggs BL, Hartmann LC : Selective Estrogen─Receptor Modulators Mechanism of action and application to clinical practice. N Engl J Med 348 : 618─629, 2003
21) Rossouw JE, Prentice RL, Manson JE, et al : Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 : 1465─1477, 2007